Free Trial

Health Catalyst (HCAT) Competitors

Health Catalyst logo
$3.01 -0.68 (-18.32%)
As of 10:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

HCAT vs. JAMF, MOMO, SPT, BLND, FSLY, DCBO, EVER, LZMH, DSP, and BMBL

Should you be buying Health Catalyst stock or one of its competitors? The main competitors of Health Catalyst include Jamf (JAMF), Hello Group (MOMO), Sprout Social (SPT), Blend Labs (BLND), Fastly (FSLY), Docebo (DCBO), EverQuote (EVER), LZ Technology (LZMH), Viant Technology (DSP), and Bumble (BMBL). These companies are all part of the "computer software" industry.

Health Catalyst vs. Its Competitors

Jamf (NASDAQ:JAMF) and Health Catalyst (NASDAQ:HCAT) are both small-cap computer software companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

Jamf has higher revenue and earnings than Health Catalyst. Jamf is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Jamf$627.40M1.77-$68.46M-$0.38-22.13
Health Catalyst$306.58M0.68-$69.50M-$1.15-2.62

Jamf has a beta of 0.36, meaning that its stock price is 64% less volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500.

93.8% of Jamf shares are held by institutional investors. Comparatively, 85.0% of Health Catalyst shares are held by institutional investors. 2.7% of Jamf shares are held by company insiders. Comparatively, 2.6% of Health Catalyst shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Health Catalyst has a consensus target price of $6.91, suggesting a potential upside of 129.23%. Given Health Catalyst's stronger consensus rating and higher possible upside, analysts clearly believe Health Catalyst is more favorable than Jamf.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jamf
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Health Catalyst
0 Sell rating(s)
6 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

In the previous week, Health Catalyst had 8 more articles in the media than Jamf. MarketBeat recorded 14 mentions for Health Catalyst and 6 mentions for Jamf. Jamf's average media sentiment score of 0.48 beat Health Catalyst's score of 0.46 indicating that Jamf is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Jamf
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Health Catalyst
2 Very Positive mention(s)
0 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Jamf has a net margin of -7.37% compared to Health Catalyst's net margin of -23.34%. Jamf's return on equity of 2.20% beat Health Catalyst's return on equity.

Company Net Margins Return on Equity Return on Assets
Jamf-7.37% 2.20% 1.00%
Health Catalyst -23.34%-6.14%-2.74%

Summary

Jamf beats Health Catalyst on 10 of the 16 factors compared between the two stocks.

Get Health Catalyst News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCAT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HCAT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCAT vs. The Competition

MetricHealth CatalystMEDICAL INFO SYS IndustryMedical SectorNASDAQ Exchange
Market Cap$212.21M$2.01B$5.46B$9.64B
Dividend YieldN/AN/A3.99%4.14%
P/E Ratio-2.6534.8230.0125.17
Price / Sales0.6849.20372.2177.01
Price / Cash10.8450.3435.9458.58
Price / Book0.509.128.155.69
Net Income-$69.50M-$63.67M$3.26B$265.48M
7 Day Performance-14.38%1.59%1.05%2.60%
1 Month Performance-25.40%-0.67%2.75%1.95%
1 Year Performance-60.08%18.61%28.06%23.97%

Health Catalyst Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCAT
Health Catalyst
3.9762 of 5 stars
$3.01
-18.3%
$6.91
+129.2%
-32.7%$212.21M$306.58M-2.651,500News Coverage
JAMF
Jamf
N/A$7.42
+0.3%
$26.43
+256.2%
-55.1%$975.80M$627.40M-19.532,595Earnings Report
Gap Up
MOMO
Hello Group
3.4936 of 5 stars
$7.97
-0.6%
$9.00
+12.9%
+21.1%$966.31M$1.45B6.131,390Positive News
SPT
Sprout Social
2.568 of 5 stars
$16.73
+1.1%
$29.17
+74.3%
-51.1%$962.22M$405.91M-16.091,140News Coverage
Earnings Report
Analyst Forecast
Gap Up
BLND
Blend Labs
3.1438 of 5 stars
$3.74
+4.9%
$4.90
+31.2%
+33.4%$924.40M$162.02M-18.671,690Earnings Report
FSLY
Fastly
3.2241 of 5 stars
$6.49
+2.0%
$8.28
+27.6%
+9.2%$920.20M$543.68M-5.951,100Trending News
Earnings Report
Analyst Upgrade
Analyst Revision
Gap Up
DCBO
Docebo
3.4221 of 5 stars
$30.34
+1.2%
$44.13
+45.4%
-20.3%$863.66M$216.93M41.00730News Coverage
Positive News
Gap Up
EVER
EverQuote
4.6117 of 5 stars
$25.76
+6.9%
$32.50
+26.2%
-0.7%$860.95M$500.19M25.26610Trending News
Earnings Report
Analyst Forecast
Analyst Revision
LZMH
LZ Technology
N/A$4.48
-21.5%
N/AN/A$856.50MN/A0.0067Gap Down
DSP
Viant Technology
2.2647 of 5 stars
$13.78
+1.1%
$21.25
+54.2%
+35.5%$852.78M$289.23M125.28350Upcoming Earnings
BMBL
Bumble
1.6649 of 5 stars
$7.70
+1.4%
$6.60
-14.3%
-20.2%$783.98M$1.07B-1.571,200Earnings Report
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:HCAT) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners